MedTrace Logo

Early Warning of Intradialytic Hypotension in Hemodialysis Patients

NCT04680039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-07-20

No results posted yet for this study

Summary

In this study, the investigators will monitor patients undergoing hemodialysis treatment with a non-invasive wearable PPG-based device. Measurements will include blood pressure, heart rate, oxygen saturation, stroke volume, cardiac output, cardiac index and systemic vascular resistance, among others. The aim is to diagnose intradialytic hypotension more rapidly than with current noninvasive methods and prevent related poor outcomes.

Conditions

  • Hypotension of Hemodialysis

Interventions

DEVICE

Continuous monitoring

Identifying intradialytic hypotension using a PPG-based wearable monitor

Sponsors & Collaborators

  • Biobeat Technologies Ltd.

    lead INDUSTRY

Principal Investigators

  • Dean Nachman, MD · The Hadassah Ein Kerem Medical Center, Jerusalem, Israel

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2022-02-15
Completion
2022-03-15
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04680039 on ClinicalTrials.gov